Yahoo Finance EN

Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why

Mar 21, 2026 &03292121202631; 10:29 UTC finance.yahoo.com

Read original on finance.yahoo.com ↗

↘

Negative for markets

Sentiment score: -40/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Truist Securities has lowered its price target for Boston Scientific Corporation (BSX) from $95 to $92, suggesting potential concerns about the company's near-term performance or valuation. This adjustment could signal caution among investors, although the full impact depends on underlying reasons not detailed in the headline. Overall, it may lead to increased volatility in BSX shares without necessarily indicating a broader market shift.

AI CONFIDENCE

65% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

BSX

BSXStock

Expected to decline

Truist Securities reduced the price target from $95 to $92, which could reflect concerns over the company's growth prospects or market conditions, potentially leading to a decline in stock price if not already priced in.

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Investors holding BSX should consider tightening stop-loss levels or waiting for more detailed analyst reports before making decisions, as this downgrade might introduce short-term pressure on the stock.

KEY SIGNALS

Analyst price target reductionPotential overvaluation concerns

SECTORS INVOLVED

Healthcare

Analysis generated on Mar 22, 2026 at 21:05 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why

RELATED INTELLIGENCE